Versant Capital Management, Inc Harmony Biosciences Holdings, Inc. Transaction History
Versant Capital Management, Inc
- $454 Million
- Q4 2024
A detailed history of Versant Capital Management, Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 155 shares of HRMY stock, worth $5,998. This represents 0.0% of its overall portfolio holdings.
Number of Shares
155
Previous 15
933.33%
Holding current value
$5,998
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
246Shares Held
45.6MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$434 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$226 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$134 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$101 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$88.2 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.29B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...